Here we report that MAGE-A10 protein expression in ovarian cancer surgical specimens reliably predicts unresponsiveness to first line platinum-based chemotherapy and poor sensitivity to platinum treatment. This evidence concerns the gene MAGEA10 and ovarian carcinoma.